Analyst Price Targets — ENSG
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 28, 2026 11:31 am | — | RBC Capital | $228.00 | $178.07 | TheFly | Ensign Group price target raised to $228 from $222 at RBC Capital |
| July 14, 2026 11:47 am | — | Truist Financial | $202.00 | $168.39 | TheFly | Ensign Group price target lowered to $202 from $215 at Truist |
| February 9, 2026 1:34 pm | — | RBC Capital | $222.00 | $198.94 | TheFly | Ensign Group price target raised to $222 from $206 at RBC Capital |
| February 6, 2026 2:52 pm | — | Truist Financial | $215.00 | $196.88 | TheFly | Ensign Group price target raised to $215 from $200 at Truist |
| February 6, 2026 1:25 pm | — | UBS | $230.00 | $197.62 | TheFly | Ensign Group price target raised to $230 from $220 at UBS |
| November 14, 2025 1:34 pm | Ben Hendrix | RBC Capital | $206.00 | $179.00 | StreetInsider | The Ensign Group Inc. (ENSG) PT Raised at RBC Capital Following Record 3Q Growth |
| November 10, 2025 3:06 pm | — | Truist Financial | $200.00 | $179.86 | TheFly | Ensign Group price target raised to $200 from $190 at Truist |
| November 5, 2025 2:28 pm | — | UBS | $220.00 | $192.62 | TheFly | Ensign Group price target raised to $220 from $205 at UBS |
| October 14, 2025 1:21 pm | David MacDonald | Truist Financial | $190.00 | $176.79 | TheFly | Ensign Group price target raised to $190 from $165 at Truist |
| September 2, 2025 11:50 am | — | UBS | $205.00 | $172.53 | TheFly | Ensign Group price target raised to $205 from $195 at UBS |
Latest News for ENSG
New York, New York--(Newsfile Corp. - September 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Ensign securities you may be…
ENSG's decentralized model is driving organic growth through higher occupancy, stronger clinical results and improved productivity across its facilities.
New York, New York--(Newsfile Corp. - September 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ: ENSG). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Ensign investor and have suffered losses, or if you have information that could assist in the Ensign investigation, you may CLICK…
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.
Canada Pension Plan Investment Board purchased a new position in The Ensign Group, Inc. (NASDAQ: ENSG) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 9,400 shares of the company's stock, valued at approximately $1,507,000. Other institutional investors have
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ENSG.
U.S. House Trading
No House trades found for ENSG.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.